Barclays
PDSB icon

Barclays’s PDS Biotechnology PDSB Stock Holding History

Barclays’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$3 – 5430
2024
Q2 		$3 Sell
1
-19,765
-100% -$63.2K ﹤0.01% 4795
2024
Q1 		$78.3K Sell
19,766
-18,636
-49% -$96K ﹤0.01% 4516
2023
Q4 		$191K Buy
38,402
+33,488
+681% +$166K ﹤0.01% 4439
2023
Q3 		$24.8K Sell
4,914
-657
-12% -$3.6K ﹤0.01% 4125
2023
Q2 		$28K Sell
5,571
-33,684
-86% -$221K ﹤0.01% 4057
2023
Q1 		$241K Buy
+39,255
New +$321K ﹤0.01% 3683
2021
Q4 		– Sell
-14,728
Closed -$219K – 4578
2021
Q3 		$219K Buy
+14,728
New +$184K ﹤0.01% 3573
2020
Q3 		– Sell
-37
Closed – – 5482
2020
Q2 		$0 Buy
+37
New +$41 ﹤0.01% 6088
2019
Q4 		– Sell
-1
Closed – – 6699
2019
Q3 		$0 Buy
+1
New +$6 ﹤0.01% 7024
2018
Q2 		– Sell
-219
Closed -$5K – 7203
2018
Q1 		$5K Buy
219
+57
+35% +$15.3K ﹤0.01% 6793
2017
Q4 		$31K Buy
162
+139
+604% +$28K ﹤0.01% 6044
2017
Q3 		$5K Buy
23
+7
+44% +$1.45K ﹤0.01% 6421
2017
Q2 		$3K Buy
16
+12
+300% +$2.36K ﹤0.01% 6354
2017
Q1 		$1K Sell
4
-16
-80% -$3.17K ﹤0.01% 6609
2016
Q4 		$5K Buy
20
+15
+300% +$3.41K ﹤0.01% 6138
2016
Q3 		$1K Sell
5
-194
-97% -$38.4K ﹤0.01% 6417
2016
Q2 		$40K Buy
+199
New +$35.2K ﹤0.01% 4954
2016
Q1 		– Sell
-6
Closed -$1K – 6370
2015
Q4 		$1K Buy
+6
New +$1.93K ﹤0.01% 5837

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's PDSB Position: Q3 2024 in Review

Barclays sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 1 share — an estimated $3 sold.

Barclays first reported a position in PDSB in Q4 2015 and held it in 18 quarters. The position peaked at $241K in Q1 2023. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • Barclays reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Barclays sold 1 PDS Biotechnology share in Q3 2024, an estimated $3.
  • Barclays first reported a position in PDS Biotechnology in Q4 2015 and held it in 18 quarters.
  • Barclays's PDS Biotechnology position peaked at $241K in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.